Cost-effectiveness analysis of scalp cooling to reduce chemotherapy-induced alopecia

References

• Hurk van den CJ, Mols F, Vingerhoets AJ, Breed WP. Impact of alopecia and scalp cooling on the well-being of breast cancer patients. Psycho-oncology 2010;19:701–9.
   PubMed Web of Science ®Google Scholar
• Carelle N, Piotto E, Bellanger A, Germanaud J, Thuillier A, Khayat D. Changing patient perceptions of the side effects of cancer chemotherapy. Cancer 2002;95:155–63.
   PubMed Web of Science ®Google Scholar
• Munstedt K, Manthey N, Sachsse S, Vahrson H. Changes in self-concept and body image during alopecia induced cancer chemotherapy. Support Care Cancer 1997;5:139–43.
   PubMed Web of Science ®Google Scholar
• Mulders M, Vingerhoets A, Breed W. The impact of cancer and chemotherapy: Perceptual similarities and differences between cancer patients, nurses and physicians. Eur J Oncol Nurs 2008;12:97–102.
   PubMed Web of Science ®Google Scholar
• Macquart-Moulin G, Viens P, Bouscary ML, Genre D, Resbeut M, Gravis G, et al. Discordance between physicians’ estimations and breast cancer patients’ self-assessment of side-effects of chemotherapy: An issue for quality of care. Br J Cancer 1997;76:1640–5.
   PubMed Web of Science ®Google Scholar
• Sukel MP, van de Poll-Franse LV, Nieuwenhuijzen GA, Vreugdenhil G, Herings RM, Coebergh JW, et al. Substantial increase in the use of adjuvant systemic treatment for early stage breast cancer reflects changes in guidelines in the period 1990–2006 in the southeastern Netherlands. Eur J Cancer 2008;44:1846–54.
   PubMed Web of Science ®Google Scholar
• Breed WPM, Hurk van den CJG, Peerbooms M. Presentation, impact and prevention of chemotherapy-induced hair loss; scalp cooling potentials and limitations. Exp Rev Dermatol 2011;6:109–25.
   Google Scholar
• Grevelman EG, Breed WP. Prevention of chemotherapy- induced hair loss by scalp cooling. Ann Oncol 2005;16: 352–8.
   PubMed Web of Science ®Google Scholar
• Auvinen PK, Mahonen UA, Soininen KM, Paananen PK, Ranta-Koponen PH, Saavalainen IE, et al. The effectiveness of a scalp cooling cap in preventing chemotherapy-induced alopecia. Tumori 2010;96:271–5.
   PubMed Web of Science ®Google Scholar
• Wang J, Lu Z, Au JL. Protection against chemotherapy- induced alopecia. Pharm Res 2006;23:2505–14.
   PubMed Web of Science ®Google Scholar
• Hussein AM. Chemotherapy-induced alopecia: New developments. South Med J 1993;86:489–96.
   PubMed Web of Science ®Google Scholar
• Trueb RM. Chemotherapy-induced alopecia. Sem Cut Med Surg 2009;28:11–4.
   PubMed Web of Science ®Google Scholar
• Benjamin B, Ziginskas D, Harman J, Meakin T. Pulsed electrostatic fields (ETG) to reduce hair loss in women undergoing chemotherapy for breast carcinoma: A pilot study. Psycho-oncology 2002;11:244–8.
   PubMed Web of Science ®Google Scholar
• Shiao TK, Shiao TK, Shiao JC. Successful treatment of chemotherapy-induced alopecia with LaserCap: A case report. Hair Transplant Forum Int 2010;156.
   Google Scholar
• Hurk van den CJG, Breed WPM, Mols F. Chemotherapy-induced hair loss. In: Preedy Ve, editors. Handbook of hair in health and disease. Wageningen, The Netherlands: Wageningen Academic Publishers; 2012. p. 403–16.
   Google Scholar
• Statistics Netherlands. Consumer price index. April 2010. [cited 2010 Sept 09]. Available from: www.cbs.nl.
   Google Scholar
• Oostenbrink JB, Bouwmans CAM, Koopmanschap MA, Rutten FFH. Handleiding voor kostenonderzoek. Methoden en standaard kostprijzen voor economische evaluaties in de gezondheidszorg. 2004 [in Dutch].
   Google Scholar
• Brazier JE, Roberts J. The estimation of a preference-based measure of health from the SF-12. Med Care 2004;42: 851–9.
   PubMed Web of Science ®Google Scholar
• Brazier JE, Rowen D, Mavranezouli I, Tsuchiya A, Young T, Yang Y, et al. Developing and testing methods for deriving preference-based measures of health from condition-specific measures (and other patient-based measures of outcome). Health Tech Assess 2012;16:1–114.
   Web of Science ®Google Scholar
• McDonough CM, Tosteson AN. Measuring preferences for cost-utility analysis: How choice of method may influence decision-making. Pharmacoeconomics 2007;25:93–106.
   PubMed Web of Science ®Google Scholar
• Stiggelbout AM, Eijkemans MJ, Kiebert GM, Kievit J, Leer JW, De Haes HJ. The ‘utility’ of the visual analog scale in medical decision making and technology assessment. Is it an alternative to the time trade-off?Int J Tech Assess Health Care 1996;12:291–8.
   PubMed Web of Science ®Google Scholar
• van Buuren S, Boshuizen HC, Knook DL. Multiple imputation of missing blood pressure covariates in survival analysis. Stat Med 1999;18:681–94.
   PubMed Web of Science ®Google Scholar
• Fenwick E, Marshall DA, Levy AR, Nichol G. Using and interpreting cost-effectiveness acceptability curves: An example using data from a trial of management strategies for atrial fibrillation. BMC Health Services Res 2006;6:52.
   PubMed Web of Science ®Google Scholar
• Council for Public Health and Health Care (Raad voor de Volksgezondheid en Zorg). Sensible and sustainable care. 2006.
   Google Scholar
• Smulders YM, Thijs A. [The cost per year of life gained: Trends and internal contradictions]. Ned Tijdschr Geneeskd 2006;150:2467–70.
   PubMedGoogle Scholar
• Bernard M, Brignone M, Adehossi A, Pefoura S, Briquet C, Chouaid C, et al. Perception of alopecia by patients requiring chemotherapy for non-small-cell lung cancer: A willingness to pay study. Lung Cancer 2011;72:114–8.
   PubMed Web of Science ®Google Scholar
• Hurk van den CJG, Akker van den-van Marle ME, Breed WPM, Poll van de-Franse LV, Nortier JWR, Coebergh JWW. Impact of scalp cooling on chemotherapy-induced alopecia, wig use and hair growth of patients with cancer. J Oncol Nurse 2013 (in press).
   Google Scholar
• Hurk van den CJ, Peerbooms M, van de Poll-Franse LV, Nortier JW, Coebergh JW, Breed WP. Scalp cooling for hair preservation and associated characteristics in 1411 chemotherapy patients – results of the Dutch Scalp Cooling Registry. Acta Oncol 2012;51:497–504.
   PubMed Web of Science ®Google Scholar
• Hurk van den CJ, Breed WP, Nortier JW. Short post-infusion scalp cooling time in the prevention of docetaxel-induced alopecia. Support Care Cancer 2012;20:3255–60.
   PubMed Web of Science ®Google Scholar
• Brazier J, Roberts J, Tsuchiya A, Busschbach J. A comparison of the EQ-5D and SF-6D across seven patient groups. Health Econ 2004;13:873–84.
   PubMed Web of Science ®Google Scholar
• Lamers LM, McDonnell J, Stalmeier PF, Krabbe PF, Busschbach JJ. The Dutch tariff: Results and arguments for an effective design for national EQ-5D valuation studies. Health Econ 2006;15:1121–32.
   PubMed Web of Science ®Google Scholar